Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.

Source:http://linkedlifedata.com/resource/pubmed/id/352505

Download in:

View as

General Info

PMID
352505